Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Total Downloads (Android)
100+
Last 28 days
Revenue
$935
AR
$11,220
MRR
$1,217
ARR
$14,604
Cash Flow Index
0.8x
Active Subscriptions
768
Active Trials
3
ARPAS
$1.21
Paid Subscriber Share (snapshot)
99.6%
Active Customers
661
New Customers
200
Subscription Penetration
116.2%
ARPU
$1.41
RPD
$1.41
ARPPU
$1.58
LTV
$14
MRR Growth (28d)
-12.4%
Subscriber Growth (28d)
-11.3%
All data is verified through RevenueCat. Last updated: Jul 27, 2026, 10:31:39 AM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$24,340
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗TrackAI
FOR SALELast 30 days rev
$24,665
MRR
$21,302
AbMaxx
FOR SALELast 30 days rev
$20,138
MRR
$6,759

Brainrot.mov
FOR SALELast 30 days rev
$9,983
MRR
$11,990
PepKit
FOR SALELast 30 days rev
$6,421
MRR
$3,390
Willo
FOR SALELast 30 days rev
$5,864
MRR
$3,649
Steady - Fear of Flying
Last 30 days rev
$6,042
MRR
$742



